NextFin News -
1) Pre-Market Performance
U.S. equity futures pointed to a broad risk-on open. Nasdaq 100 futures traded at 28,676.8, up 394.5 points (+1.39%). S&P 500 futures rose to 7,512.5, up 65.0 points (+0.87%). Dow Jones futures advanced to 52,703, up 579 points (+1.11%).
European equities strengthened: the FTSE 100 at 10,801.83 (+0.61%), intraday range 10,736.14–10,812.05; France’s CAC 40 at 8,455.50 (+0.99%); Germany’s DAX at 25,536.04 (+1.74%).
In commodities and FX, oil fell as geopolitical risk premia eased. Brent crude futures were near $85.98 (-6.22%), while WTI crude futures traded around $83.31 (-6.72%). Gold futures rose to about $4,101.45 (up $30.65, +0.75%); spot gold was reported near $4,089 per ounce. The U.S. dollar index was lower near 101.20 (down roughly 0.10%).
2) Hot News
- U.S.-Iran pause boosts risk appetite: U.S. stock futures rose after the United States and Iran paused hostilities, easing inflation concerns tied to energy prices and lifting rate-sensitive and travel-linked shares while pressuring energy producers.
- Oil tumbles, but shipping risks remain: Brent and WTI fell more than 5% as traders priced in a lower near-term supply disruption risk around the Strait of Hormuz, though Red Sea shipping risks persisted following Houthi attacks on Saudi oil infrastructure.
- Gold rises as dollar softens: Gold gained as the dollar index slipped and Treasury yields eased, with spot gold and U.S. futures both advancing amid a calmer geopolitical backdrop.
- AI-linked names rebound as energy shares lag: AI infrastructure and chip-linked stocks drew fresh attention after reports of large financing discussions tied to OpenAI data-center expansion, while oil-sensitive energy producers weakened on the crude sell-off.
3) U.S. Stock Focus
- Baker Hughes — Q2 beat lifts shares: Baker Hughes rose about 2% after reporting adjusted EPS of $0.64 (vs. $0.49 est.) on revenue of $6.74 billion (consensus $6.52 billion); orders totaled $10.5 billion, including $7.1 billion from Industrial & Energy Technology.
- Tesla — UK 5G patent case revived: Tesla won a Supreme Court bid to revive a London lawsuit seeking fair FRAND licensing for 5G patents ahead of its planned 5G vehicle rollout; the case returns to the High Court.
- Capricor Therapeutics — FDA documents pressure shares: Capricor fell about 40% after FDA briefing documents were posted ahead of a July 29 advisory committee meeting reviewing the resubmitted BLA for deramiocel in Duchenne-associated cardiomyopathy.
- Gossamer Bio — Regulatory update sparks rally: Gossamer surged 37.7% after confirming it remains on track to submit an NDA for seralutinib in pulmonary arterial hypertension in September 2026 and reacquired worldwide rights from Chiesi without upfront cash.
- D-Wave Quantum — AT&T expands quantum technology use: D-Wave jumped about 11% after AT&T expanded use of its annealing quantum computing technology across network operations and plans to integrate it into agentic AI tools.
- Nvidia — OpenAI financing discussions in focus: Nvidia attracted attention over reports it is discussing roughly $250 billion in financing guarantees for OpenAI’s Ohio data-center project and potential support for up to $350 billion in chip purchases.
- CoreWeave — AI infrastructure read-through supports shares: CoreWeave rose about 4% as investors reacted to reports of major financing tied to OpenAI’s data-center expansion, highlighting interest in AI compute and data-center demand.
- Outlook Therapeutics — FDA approval and upgrade extend gains: Outlook climbed 8.9% following last week’s FDA approval of LYTENAVA for wet AMD and a BTIG upgrade to Buy with a $4.00 target.
- Robert Half — BMO upgrade lifts staffing stock: Robert Half advanced about 1.2% after BMO upgraded the company to Outperform, citing signs the cyclical bottom occurred in Q2 and expecting revenue growth and margin expansion into Q3.
Explore more exclusive insights at nextfin.ai.
